Algorae Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	25	6	11	16	7	5
Market Cap Growth	191.96%	-50.87%	-27.72%	119.87%	37.80%	8.71%
Enterprise Value	24	4	9	14	4	4
Last Close Price	0.01	0.01	0.01	0.01	0.01	0.01
PS Ratio	-	-	-	-	3019.57	25.57
PB Ratio	17.22	3.79	5.60	6.22	2.55	4.98
P/TBV Ratio	17.22	3.79	5.60	6.22	2.55	4.98
EV/Sales Ratio	-	-	-	-	1723.99	17.81
Asset Turnover	-	-	-	-	0.00	0.11
Quick Ratio	13.90	13.90	17.66	9.35	17.84	6.13
Current Ratio	14.13	14.13	17.89	9.35	17.84	6.13
Return on Equity (ROE)	-30.63%	-30.63%	-61.85%	-54.06%	-72.33%	-68.64%
Return on Assets (ROA)	-23.85%	-23.85%	-28.78%	-22.41%	-30.84%	-33.30%
Return on Capital Employed (ROCE)	-47.90%	-47.90%	-56.60%	-40.40%	-36.20%	-97.40%
Earnings Yield	-2.09%	-9.52%	-12.42%	-9.01%	-19.04%	-21.30%
FCF Yield	-	-9.31%	-9.03%	-8.49%	-19.90%	-21.32%
Buyback Yield / Dilution	-1.46%	-1.46%	-23.47%	-53.82%	-53.24%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.